Prediction of antibody persistency from antibody titres to natalizumab
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Prediction of antibody persistency from antibody titres to natalizumab. / Jensen, Poul Erik H; Koch-Henriksen, Nils; Sellebjerg, Finn; Sørensen, Per S.
I: Multiple Sclerosis, Bind 18, Nr. 10, 2012, s. 1493-9.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Prediction of antibody persistency from antibody titres to natalizumab
AU - Jensen, Poul Erik H
AU - Koch-Henriksen, Nils
AU - Sellebjerg, Finn
AU - Sørensen, Per S
PY - 2012
Y1 - 2012
N2 - In a subgroup of patients with multiple sclerosis natalizumab therapy causes generation of anti-natalizumab antibodies that may be transient or persistent. It is recommended to discontinue natalizumab therapy in persistently antibody-positive patients.
AB - In a subgroup of patients with multiple sclerosis natalizumab therapy causes generation of anti-natalizumab antibodies that may be transient or persistent. It is recommended to discontinue natalizumab therapy in persistently antibody-positive patients.
U2 - 10.1177/1352458512441688
DO - 10.1177/1352458512441688
M3 - Journal article
C2 - 22454098
VL - 18
SP - 1493
EP - 1499
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
SN - 1352-4585
IS - 10
ER -
ID: 48569358